This study aimed to validate the agreement and diagnostic performance of a deep-learning-based coronary artery calcium scoring (DL-CACS) system for ECG-gated and non-gated low-dose chest CT (LDCT) across multivendor datasets. In this retrospective study, datasets from Seoul National University Hospital (SNUH, 652 paired ECG-gated and non-gated CT scans) and the Stanford public dataset (425 ECG-gated and 199 non-gated CT scans) were analyzed. Agreement metrics included intraclass correlation coefficient (ICC), coefficient of determination (R²), and categorical agreement (κ). Diagnostic performance was assessed using categorical accuracy and the area under the receiver operating characteristic curve (AUROC). DL-CACS demonstrated excellent performance for ECG-gated CT in both datasets (SNUH: R² = 0.995, ICC = 0.997, κ = 0.97, AUROC = 0.99; Stanford: R² = 0.989, ICC = 0.990, κ = 0.97, AUROC = 0.99). For non-gated CT using manual LDCT CAC scores as a reference, performance was similarly high (R² = 0.988, ICC = 0.994, κ = 0.96, AUROC = 0.98-0.99). When using ECG-gated CT scores as the reference, performance for non-gated CT was slightly lower but remained robust (SNUH: R² = 0.948, ICC = 0.968, κ = 0.88, AUROC = 0.98-0.99; Stanford: R² = 0.949, ICC = 0.948, κ = 0.71, AUROC = 0.89-0.98). DL-CACS provides a reliable and automated solution for CACS, potentially reducing workload while maintaining robust performance in both ECG-gated and non-gated CT settings. Question How accurate and reliable is deep-learning-based coronary artery calcium scoring (DL-CACS) in ECG-gated CT and non-gated low-dose chest CT (LDCT) across multivendor datasets? Findings DL-CACS showed near-perfect performance for ECG-gated CT. For non-gated LDCT, performance was excellent using manual scores as the reference and lower but reliable when using ECG-gated CT scores. Clinical relevance DL-CACS provides a reliable and automated solution for CACS, potentially reducing workload and improving diagnostic workflow. It supports cardiovascular risk stratification and broader clinical adoption, especially in settings where ECG-gated CT is unavailable.

To evaluate the predictive ability of AI HIP in determining the size and position of prostheses during complex total hip arthroplasty (THA). Additionally, it investigates the factors influencing the accuracy of preoperative planning predictions. From April 2021 to December 2023, patients with complex hip joint diseases were divided into the AI preoperative planning group (n = 29) and the X-ray preoperative planning group (n = 27). Postoperative X-rays were used to measure acetabular anteversion angle, abduction angle, tip-to-sternum distance, intraoperative duration, blood loss, planning time, postoperative Harris Hip Scores (at 2 weeks, 3 months, and 6 months), and visual analogue scale (VAS) pain scores (at 2 weeks and at final follow-up) to analyze clinical outcomes. On the acetabular side, the accuracy of AI preoperative planning was higher compared to X-ray preoperative planning (75.9% vs. 44.4%, P = 0.016). On the femoral side, AI preoperative planning also showed higher accuracy compared to X-ray preoperative planning (85.2% vs. 59.3%, P = 0.033). The AI preoperative planning group showed superior outcomes in terms of reducing bilateral leg length discrepancy (LLD), decreasing operative time and intraoperative blood loss, early postoperative recovery, and pain control compared to the X-ray preoperative planning group (P < 0.05). No significant differences were observed between the groups regarding bilateral femoral offset (FO) differences, bilateral combined offset (CO) differences, abduction angle, anteversion angle, or tip-to-sternum distance. Factors such as gender, age, affected side, comorbidities, body mass index (BMI) classification, bone mineral density did not affect the prediction accuracy of AI HIP preoperative planning. Artificial intelligence-based 3D planning can be effectively utilized for preoperative planning in complex THA. Compared to X-ray templating, AI demonstrates superior accuracy in prosthesis measurement and provides significant clinical benefits, particularly in early postoperative recovery.

Microsatellite instability (MSI) is a novel predictive biomarker for chemotherapy and immunotherapy response, as well as prognostic indicator in colorectal cancer (CRC). The current standard for MSI identification is polymerase chain reaction (PCR) testing or the immunohistochemical analysis of tumor biopsy samples. However, tumor heterogeneity and procedure complications pose challenges to these techniques. CT and MRI-based radiomics models offer a promising non-invasive approach for this purpose. A systematic search of PubMed, Embase, Cochrane Library and Scopus was conducted to identify studies evaluating the diagnostic performance of CT and MRI-based radiomics models for detecting MSI status in CRC. Pooled area under the curve (AUC), sensitivity, and specificity were calculated in RStudio using a random-effects model. Forest plots and a summary ROC curve were generated. Heterogeneity was assessed using I² statistics and explored through sensitivity analyses, threshold effect assessment, subgroup analyses and meta-regression. 17 studies with a total of 6,045 subjects were included in the analysis. All studies extracted radiomic features from CT or MRI images of CRC patients with confirmed MSI status to train machine learning models. The pooled AUC was 0.815 (95% CI: 0.784-0.840) for CT-based studies and 0.900 (95% CI: 0.819-0.943) for MRI-based studies. Significant heterogeneity was identified and addressed through extensive analysis. Radiomics models represent a novel and promising tool for predicting MSI status in CRC patients. These findings may serve as a foundation for future studies aimed at developing and validating improved models, ultimately enhancing the diagnosis, treatment, and prognosis of colorectal cancer.

Interest has grown in combining radiology, pathology, genomic, and clinical data to improve the accuracy of diagnostic and prognostic predictions toward precision health. However, most existing works choose their datasets and modeling approaches empirically and in an ad hoc manner. A prior study proposed four partial information decomposition (PID)-based metrics to provide a theoretical understanding of multimodal data interactions: redundancy, uniqueness of each modality, and synergy. However, these metrics have only been evaluated in a limited collection of biomedical data, and the existing work does not elucidate the effect of parameter selection when calculating the PID metrics. In this work, we evaluate PID metrics on a wider range of biomedical data, including clinical, radiology, pathology, and genomic data, and propose potential improvements to the PID metrics. We apply the PID metrics to seven different modality pairs across four distinct cohorts (datasets). We compare and interpret trends in the resulting PID metrics and downstream model performance in these multimodal cohorts. The downstream tasks being evaluated include predicting the prognosis (either overall survival or recurrence) of patients with non-small cell lung cancer, prostate cancer, and glioblastoma. We found that, while PID metrics are informative, solely relying on these metrics to decide on a fusion approach does not always yield a machine learning model with optimal performance. Of the seven different modality pairs, three had poor (0%), three had moderate (66%-89%), and only one had perfect (100%) consistency between the PID values and model performance. We propose two improvements to the PID metrics (determining the optimal parameters and uncertainty estimation) and identified areas where PID metrics could be further improved. The current PID metrics are not accurate enough for estimating the multimodal data interactions and need to be improved before they can serve as a reliable tool. We propose improvements and provide suggestions for future work. Code: https://github.com/zhtyolivia/pid-multimodal.

Traditional diagnostic methods for major depressive disorder (MDD), which rely on subjective assessments, may compromise diagnostic accuracy. In contrast, machine learning models have the potential to classify and diagnose MDD more effectively, reducing the risk of misdiagnosis associated with conventional methods. The aim of this meta-analysis is to evaluate the overall classification accuracy of machine learning models in MDD and examine the effects of machine learning algorithms, biomarkers, diagnostic comparison groups, validation procedures, and participant age on classification performance. As of September 2024, a total of 176 studies were ultimately included in the meta-analysis, encompassing a total of 60,926 participants. A random-effects model was applied to analyze the extracted data, resulting in an overall classification accuracy of 0.825 (95% CI [0.810; 0.839]). Convolutional neural networks significantly outperformed support vector machines (SVM) when using electroencephalography and magnetoencephalography data. Additionally, SVM demonstrated significantly better performance with functional magnetic resonance imaging data compared to graph neural networks and gaussian process classification. The sample size was negatively correlated to classification accuracy. Furthermore, evidence of publication bias was also detected. Therefore, while this study indicates that machine learning models show high accuracy in distinguishing MDD from healthy controls and other psychiatric disorders, further research is required before these findings can be generalized to large-scale clinical practice.

Three-dimensional (3D) ultrasound (US) reconstruction is of significant value in clinical diagnosis, characterized by its safety, portability, low cost, and high real-time capabilities. 3D freehand ultrasound reconstruction aims to eliminate the need for tracking devices, relying solely on image data to infer the spatial relationships between frames. However, inherent jitter during handheld scanning introduces significant inaccuracies, making current methods ineffective in precisely predicting the spatial motions of ultrasound image frames. This leads to substantial cumulative errors over long sequence modeling, resulting in deformations or artifacts in the reconstructed volume. To address these challenges, we proposed UltrasOM, a 3D ultrasound reconstruction network designed for spatial relative motion estimation. Initially, we designed a video embedding module that integrates optical flow dynamics with original static information to enhance motion change features between frames. Next, we developed a Mamba-based spatiotemporal attention module, utilizing multi-layer stacked Space-Time Blocks to effectively capture global spatiotemporal correlations within video frame sequences. Finally, we incorporated correlation loss and motion speed loss to prevent overfitting related to scanning speed and pose, enhancing the model's generalization capability. Experimental results on a dataset of 200 forearm cases, comprising 58,011 frames, demonstrated that the proposed method achieved a final drift rate (FDR) of 10.24 %, a frame-to-frame distance error (DE) of 7.34 mm, a symmetric Hausdorff distance error (HD) of 10.81 mm, and a mean angular error (MEA) of 2.05°, outperforming state-of-the-art methods by 13.24 %, 15.11 %, 3.57 %, and 6.32 %, respectively. By integrating optical flow features and deeply exploring contextual spatiotemporal dependencies, the proposed network can directly predict the relative motions between multiple frames of ultrasound images without the need for tracking, surpassing the accuracy of existing methods.

Late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) imaging is considered the in vivo reference standard for assessing infarct size (IS) and microvascular obstruction (MVO) in ST-elevation myocardial infarction (STEMI) patients. However, the exact quantification of those markers of myocardial infarct severity remains challenging and very time-consuming. As LGE distribution patterns can be quite complex and hard to delineate from the blood pool or epicardial fat, automatic segmentation of LGE CMR images is challenging. In this work, we propose a cascaded framework of two-dimensional and three-dimensional convolutional neural networks (CNNs) which enables to calculate the extent of myocardial infarction in a fully automated way. By artificially generating segmentation errors which are characteristic for 2D CNNs during training of the cascaded framework we are enforcing the detection and correction of 2D segmentation errors and hence improve the segmentation accuracy of the entire method. The proposed method was trained and evaluated on two publicly available datasets. We perform comparative experiments where we show that our framework outperforms state-of-the-art reference methods in segmentation of myocardial infarction. Furthermore, in extensive ablation studies we show the advantages that come with the proposed error correcting cascaded method. The code of this project is publicly available at https://github.com/matthi99/EcorC.git.

Microwave thermotherapy is a promising approach for cancer treatment, but accurate noninvasive temperature monitoring remains challenging. This study aims to achieve accurate temperature prediction during microwave thermotherapy by efficiently integrating multi-feature data, thereby improving the accuracy and reliability of noninvasive thermometry techniques. We proposed an enhanced recurrent neural network architecture, namely CirnetamorNet. The experimental data acquisition system is developed by using the material that simulates the characteristics of human tissue to construct the body model. Ultrasonic image data at different temperatures were collected, and 5 parameters with high temperature correlation were extracted from gray scale covariance matrix and Homodyned-K distribution. Using multi-feature data as input and temperature prediction as output, the CirnetamorNet model is constructed by multi-head attention mechanism. Model performance was evaluated by analyzing training losses, predicting mean square error and accuracy, and ablation experiments were performed to evaluate the contribution of each module. Compared with common models, the CirnetamorNet model performs well, with training losses as low as 1.4589 and mean square error of only 0.1856. Its temperature prediction accuracy of 0.3°C exceeds that of many advanced models. Ablation experiments show that the removal of any key module of the model will lead to performance degradation, which proves that the collaboration of all modules is significant for improving the performance of the model. The proposed CirnetamorNet model exhibits exceptional performance in noninvasive thermometry for microwave thermotherapy. It offers a novel approach to multi-feature data fusion in the medical field and holds significant practical application value.

To evaluate the diagnostic performance of the PET Assisted Reporting System (PARS) in nasopharyngeal carcinoma (NPC) patients without distant metastasis, and to investigate the prognostic significance of the metabolic parameters. Eighty-three NPC patients who underwent pretreatment 18F-FDG PET/CT were retrospectively collected. First, the sensitivity, specificity, and accuracy of PARS for diagnosing malignant lesions were calculated, using histopathology as the gold standard. Next, metabolic parameters of the primary tumor were derived using both PARS and manual segmentation. The differences and consistency between the 2 methods were analyzed. Finally, the prognostic value of PET metabolic parameters was evaluated. Prognostic analysis of progression-free survival (PFS) and overall survival (OS) was conducted. PARS demonstrated high patient-based accuracy (97.2%), sensitivity (88.9%), and specificity (97.4%), and 96.7%, 84.0%, and 96.9% based on lesions. Manual segmentation yielded higher metabolic tumor volume (MTV) and total lesion glycolysis (TLG) than PARS. Metabolic parameters from both methods were highly correlated and consistent. ROC analysis showed metabolic parameters exhibited differences in prognostic prediction, but generally performed well in predicting 3-year PFS and OS overall. MTV and age were independent prognostic factors; Cox proportional-hazards models incorporating them showed significant predictive improvements when combined. Kaplan-Meier analysis confirmed better prognosis in the low-risk group based on combined indicators (χ² = 42.25, P < 0.001; χ² = 20.44, P < 0.001). Preliminary validation of PARS in NPC patients without distant metastasis shows high diagnostic sensitivity and accuracy for lesion identification and classification, and metabolic parameters correlate well with manual. MTV reflects prognosis, and its combination with age enhances prognostic prediction and risk stratification.

This study evaluates adherence to the latest Society for Vascular Surgery (SVS) guidelines on imaging surveillance, physician evaluation, and surgical intervention for abdominal aortic aneurysm (AAA). AI-based natural language processing applied retrospectively identified AAA patients from imaging scans at a tertiary care center between January-March 2019 and 2021, excluding the pandemic period. Retrospective chart review assessed demographics, comorbidities, imaging, and follow-up adherence. Statistical significance was set at p<0.05. Among 479 identified patients, 279 remained in the final cohort following exclusion of deceased patients. Imaging surveillance adherence was 67.7% (189/279), with males comprising 72.5% (137/189) (Figure 1). The mean age for adherent patients was 73.9 (SD ±9.5) vs. 75.2 (SD ±10.8) for non-adherent patients (Table 1). Adherent females were significantly younger than non-adherent females (76.7 vs. 81.1 years; p=0.003) with no significant age difference in adherent males. Adherent patients were more likely to be evaluated by a vascular provider within six months (p<0.001), but aneurysm size did not affect imaging adherence: 3.0-4.0cm (p=0.24), 4.0-5.0cm (p=0.88), >5.0cm (p=0.29). Based on SVS surgical criteria, 18 males (AAA >5.5cm) and 17 females (AAA >5.0cm) qualified for intervention and repair rates increased in 2021. 34 males (20 in 2019 v. 14 in 2021) and 7 females (2021 only) received surgical intervention below the threshold for repair. Despite consistent SVS guidelines, adherence remains moderate. AI-based detection and follow-up algorithms may enhance adherence and long-term AAA patient outcomes, however further research is needed to assess the specific impacts of AI.